MA28980B1 - 1, 1, 2, 2-TETRA (HETERO) ARYLETHANES OR 1, 1, 2-TRI (HETERO) ARYL-2-HETEROCYCLYLETHANES AS INHIBITORS OF POTASSIUM CHANNELS - Google Patents

1, 1, 2, 2-TETRA (HETERO) ARYLETHANES OR 1, 1, 2-TRI (HETERO) ARYL-2-HETEROCYCLYLETHANES AS INHIBITORS OF POTASSIUM CHANNELS

Info

Publication number
MA28980B1
MA28980B1 MA29689A MA29689A MA28980B1 MA 28980 B1 MA28980 B1 MA 28980B1 MA 29689 A MA29689 A MA 29689A MA 29689 A MA29689 A MA 29689A MA 28980 B1 MA28980 B1 MA 28980B1
Authority
MA
Morocco
Prior art keywords
hetero
inhibitors
heterocyclylethanes
arylethanes
tetra
Prior art date
Application number
MA29689A
Other languages
French (fr)
Inventor
Mark T Bilodeau
Zhicai Wu
John Hartnett
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of MA28980B1 publication Critical patent/MA28980B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Cette invention porte sur des composés représentés par la structure (1) utiles en tant qu'inhibiteurs de canal potassique dans le traitement des arythmies cardiaques et autres maladies similaires.This invention relates to compounds represented by structure (1) useful as potassium channel inhibitors in the treatment of cardiac arrhythmias and other similar diseases.

MA29689A 2004-07-29 2007-02-21 1, 1, 2, 2-TETRA (HETERO) ARYLETHANES OR 1, 1, 2-TRI (HETERO) ARYL-2-HETEROCYCLYLETHANES AS INHIBITORS OF POTASSIUM CHANNELS MA28980B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59218104P 2004-07-29 2004-07-29

Publications (1)

Publication Number Publication Date
MA28980B1 true MA28980B1 (en) 2007-11-01

Family

ID=35613661

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29689A MA28980B1 (en) 2004-07-29 2007-02-21 1, 1, 2, 2-TETRA (HETERO) ARYLETHANES OR 1, 1, 2-TRI (HETERO) ARYL-2-HETEROCYCLYLETHANES AS INHIBITORS OF POTASSIUM CHANNELS

Country Status (15)

Country Link
KR (1) KR20070043985A (en)
AR (1) AR049847A1 (en)
BR (1) BRPI0513793A (en)
CR (1) CR8876A (en)
EC (1) ECSP077208A (en)
IL (1) IL180846A0 (en)
MA (1) MA28980B1 (en)
MX (1) MX2007001188A (en)
NO (1) NO20071107L (en)
PE (1) PE20060382A1 (en)
RU (1) RU2344134C2 (en)
TW (1) TW200607493A (en)
UA (1) UA88018C2 (en)
WO (1) WO2006028590A1 (en)
ZA (1) ZA200700477B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2408440B1 (en) * 2009-03-18 2016-05-11 Medicure International Inc. Transdermal pharmaceutical preparation and administration of tirofiban
WO2013188254A1 (en) 2012-06-11 2013-12-19 Bristol-Myers Squibb Company Phosphoramidic acid prodrugs of 5 - [5 - phenyl- 4 - (pyridin- 2 - ylmethylamino) quinazolin- 2 - yl] pyridine- 3 - sulfonamide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1465863B1 (en) * 2002-01-04 2008-07-09 NeuroSearch A/S Potassium channel modulators

Also Published As

Publication number Publication date
RU2007107408A (en) 2008-09-10
NO20071107L (en) 2007-04-19
ZA200700477B (en) 2009-08-26
WO2006028590A1 (en) 2006-03-16
AR049847A1 (en) 2006-09-06
IL180846A0 (en) 2007-06-03
KR20070043985A (en) 2007-04-26
CR8876A (en) 2007-08-28
PE20060382A1 (en) 2006-05-15
ECSP077208A (en) 2007-02-28
TW200607493A (en) 2006-03-01
RU2344134C2 (en) 2009-01-20
UA88018C2 (en) 2009-09-10
BRPI0513793A (en) 2008-05-13
MX2007001188A (en) 2007-03-21

Similar Documents

Publication Publication Date Title
MA31906B1 (en) HIV inhibitors
MA29817B1 (en) PROLINAMIDE DERIVATIVES AS MODULATORS OF THE SODIUM CHANNEL
EA200802213A1 (en) METHODS OF TREATING BLOOD DISEASES
ATE440087T1 (en) 2,4-DIAMINOPYRIMIDENE DERIVATIVES THAT ARE SUITABLE AS INHIBITORS OF PKC-THETA
MA28935B1 (en) PREPARATION AND USE OF BIPHENYL-4-YL CARBONYLAMINO ACID DERIVATIVES IN THE TREATMENT OF OBESITY
BRPI0408369A (en) indole derivatives useful for treating disease
MA30427B1 (en) BICYCLIC DERIVATIVES USED AS CETP INHIBITORS
UA85559C2 (en) Aminobenzophenone compounds
PT1543011E (en) COMPOSITION OF TIENOPYROLYL AND FURANOPYROLYL AND ITS USE AS LIGANDS OF HISTAMINE H4 RECEPTOR
DE602004024572D1 (en) COMPOSITIONS SUITED AS INHIBITORS OF PROTEIN KINASES
EA201370001A1 (en) ANTI-VIRAL COMPOSITIONS FOR LOCAL APPLICATION
MY139690A (en) Sulfonamide derivatives for the treatment of diseases.
MY143390A (en) Sulfonamide derivatives for the treatment of diseases.
EA200700934A1 (en) PYRIMIDINE DERIVATIVES AND THEIR APPLICATION AS CB2 MODULATORS
EA200301232A1 (en) NEW ARYL SULPHONAMIDE CONNECTIONS AND THEIR APPLICATION FOR TREATMENT OF OBESITY, TYPE II DIABETES AND CENTRAL NERVOUS DISORDERS
EP1673078A4 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
BRPI0508537A (en) Ion channel modulators
EA200601462A1 (en) CONNECTIONS FOR THE TREATMENT OF DISEASES
NO20060278L (en) Piperazine derivatives and methods of use
MXPA05009535A (en) N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses.
EP1689713A4 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer s disease
BR0314053A (en) Pyrazolopyridines and methods of obtaining and using them
EA200601217A1 (en) NEW CONDENSED PYRROCARBAZOLES
EA200601219A1 (en) NEW CONDENSED PYRROCARBAZOLES
BRPI0411085A (en) compound, pharmaceutical composition, use of a compound, and methods for the treatment or prophylaxis of oncogenic viruses, and conditions or disorders due to hpv infection